Pioglitazone safe and effective for steatohepatitis in T2DM

Long-term pioglitazone is not only safe for patients with nonalcoholic steatohepatitis (NASH) and prediabetes or type 2 diabetes but is associated with significant improvements in fatty liver disease...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news